Offer - Urjas Oil for just ₹ 1 X
New GTN 6.4 Tablet CR (30) is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Angina. Other than this, New GTN 6.4 Tablet CR (30) has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of New GTN 6.4 Tablet CR (30) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of New GTN 6.4 Tablet CR (30) as well, which are listed below. Normally, these side effects of New GTN 6.4 Tablet CR (30) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that New GTN 6.4 Tablet CR (30) has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if New GTN 6.4 Tablet CR (30) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the New GTN 6.4 Tablet CR (30) related warnings section.
New GTN 6.4 Tablet CR (30) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Anemia, Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by New GTN 6.4 Tablet CR (30) are listed in the contraindications section below.
Drug reaction of New GTN 6.4 Tablet CR (30) with other medicines has been reported. See below for a complete list.
You should also be aware that New GTN 6.4 Tablet CR (30) is not safe while driving, and is not addiction.
New GTN 6.4 Tablet CR (30) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of New GTN 6.4 Tablet CR (30) safe for pregnant women?
Pregnant women may experience moderate side effects from New GTN. It is best to stop taking New GTN immediately and inform your doctor if you notice any discomfort.
Is the use of New GTN 6.4 Tablet CR (30) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of New GTN. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of New GTN 6.4 Tablet CR (30) on the Kidneys?
There are no side effects of New GTN on the kidneys.
What is the effect of New GTN 6.4 Tablet CR (30) on the Liver?
New GTN is rarely harmful for the liver.
What is the effect of New GTN 6.4 Tablet CR (30) on the Heart?
Side effects of New GTN rarely affect the heart.
If you are suffering from any of the following diseases, you should not take New GTN 6.4 Tablet CR (30) unless your doctor advises you to do so -
Is this New GTN 6.4 Tablet CR (30) habit forming or addictive?
New GTN 6.4 Tablet CR (30) does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking New GTN 6.4 Tablet CR (30). So it is best to avoid driving.
Is it safe?
New GTN 6.4 Tablet CR (30) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, New GTN 6.4 Tablet CR (30) is not used to treat mental disorders.
Interaction between Food and New GTN 6.4 Tablet CR (30)
You can take New GTN 6.4 Tablet CR (30) with food.
Interaction between Alcohol and New GTN 6.4 Tablet CR (30)
No research has been done on this till date. Therefore, it is not known what the effect of taking New GTN 6.4 Tablet CR (30) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 916-917
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 542-543
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nitrostat® (nitroglycerin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gonitro (nitroglycerin)